PR NEWS Logo
Home
PR NewsWire
NewsWire Today
MarketWire
Submit Your Feeds
Business News
•
MarketWire
• Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million
Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million
Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million
NEW YORK, NY--(Marketwire - April 4, 2011) - Royalty Pharma announced today that it has acquired the rights to certain royalties payable on sales of Lexiscan® and Cubicin® from an undisclosed seller for a cash payment of $487 million.
View More :
http://www.marketwire.com/mw/release.do?id=1422399&sourceType=3
Releted News by marketwire
John Thomas Financial Releases Chief Economist Mike Norman's Analysis and Commentary on Government Shutdown
Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million
E-Tailer Vistaprint Taps Cotendo to Accelerate Worldwide Website Delivery and SSL